Skip to main content
Non-coding RNA Research logoLink to Non-coding RNA Research
. 2020 Nov 7;5(4):219. doi: 10.1016/j.ncrna.2020.11.001

Erratum regarding previously published articles

PMCID: PMC7689510  PMID: 33294747

Owing to a Publisher error, Declaration/Conflict of Interest statements were not included in the published versions of the following articles, that appeared in previous issues of Non-coding RNA Research.

The appropriate Declaration/Conflict of Interest statements, provided by the Authors, are included below.

  • 1.

    “Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction” (Non-coding RNA Research, 2018; 3/4: 178–187) https://doi.org/10.1016/j.ncrna.2018.09.001 Declaration of interest: The Authors have no interests to declare.

  • 2.

    “The eminent roles of ncRNAs in the pathogenesis of psoriasis” (Non-coding RNA Research, 2020; 5/3: 99–108) https://doi.org/10.1016/j.ncrna.2020.06.002 Declaration of interest: The Authors have no interests to declare.

  • 3.

    “Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma” (Non-coding RNA Research, 2018; 3/4: 213–225) https://doi.org/10.1016/j.ncrna.2018.11.001 Declaration of interest: The Authors have no interests to declare.

  • 4.

    “Relations between approved platinum drugs and non-coding RNAs in mesothelioma” (Non-coding RNA Research, 2018; 3/4: 161–173) https://doi.org/10.1016/j.ncrna.2018.08.001 Declaration of interest: The Authors have no interests to declare.

  • 5.

    “Nuclear paraspeckles function in mediating gene regulatory and apoptotic pathways” (Non-coding RNA Research, 2020; 4/4: 128–134) https://doi.org/10.1016/j.ncrna.2019.11.002 Declaration of interest: The Authors have no interests to declare.

  • 6.

    “The noncoding-RNA landscape in cardiovascular health and disease” (Non-coding RNA Research, 2018; 3/1: 12–19) https://doi.org/10.1016/j.ncrna.2018.02.001 Declaration of interest: The Authors have no interests to declare.

  • 7.

    “Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?” (Non-coding RNA Research, 2020; 5/2: 41–47) https://doi.org/10.1016/j.ncrna.2020.02.005 Declaration of interest: The Authors have no interests to declare.

  • 8.

    “miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools” (Non-coding RNA Research, 2019; 4/1: 30–35) https://doi.org/10.1016/j.ncrna.2019.01.002 Declaration of interest: The Authors have no interests to declare.

  • 9.

    “MicroRNA-486–5p and microRNA-486–3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions” (Non-coding RNA Research, 2020; 5/1: 11–21) https://doi.org/10.1016/j.ncrna.2020.01.001 Declaration of interest: The Authors have no interests to declare.

  • 10.

    “Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs” (Non-coding RNA Research, 2018; 3/2: 42–53) https://doi.org/10.1016/j.ncrna.2018.04.001 Declaration of interest: The Authors have no interests to declare.

  • 11.

    “Long non-coding RNAs: Functional regulatory players in breast cancer” (Non-coding RNA Research, 2019; 4/1: 36–44) https://doi.org/10.1016/j.ncrna.2019.01.003 Declaration of interest: The Authors have no interests to declare.

  • 12.

    “Carcinogenesis in prostate cancer: The role of long non-coding RNAs” (Non-coding RNA Research, 2018; 3/1: 29–38) https://doi.org/10.1016/j.ncrna.2018.01.001 Declaration of interest: The Authors have no interests to declare.

  • 13.

    “NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found?” (Non-coding RNA Research, 2018; 3/4: 243–252) https://doi.org/10.1016/j.ncrna.2018.11.003 Declaration of interest: The Authors have no interests to declare.


Articles from Non-coding RNA Research are provided here courtesy of KeAi Publishing

RESOURCES